Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Therapeutic vaccines: realities of today and hopes for tomorrow.

Sela M, Hilleman MR.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14559. Epub 2004 Sep 21. No abstract available.

2.

Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections.

Hilleman MR.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14560-6. Epub 2004 Aug 5. Review.

4.

Personal reflections on twentieth century vaccinology.

Hilleman MR.

Southeast Asian J Trop Med Public Health. 2003 Jun;34(2):244-8.

PMID:
12971543
5.
6.

Overview: past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B.

Hilleman MR.

J Gastroenterol Hepatol. 2002 Dec;17 Suppl:S449-51. Review. No abstract available.

PMID:
12534776
7.

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.

Hilleman MR.

Vaccine. 2002 Aug 19;20(25-26):3068-87. Review.

PMID:
12163258
8.

Overview: cause and prevention in biowarfare and bioterrorism.

Hilleman MR.

Vaccine. 2002 Aug 19;20(25-26):3055-67. Review.

PMID:
12163257
9.
10.
11.

Overview of vaccinology with special reference to papillomavirus vaccines.

Hilleman MR.

J Clin Virol. 2000 Oct;19(1-2):79-90. Review.

PMID:
11091151
12.
13.

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.

Hilleman MR.

Vaccine. 2000 Feb 14;18(15):1436-47. Review.

PMID:
10618541
14.

International biological standardization in historic and contemporary perspective.

Hilleman MR.

Dev Biol Stand. 1999;100:19-30. Review.

PMID:
10616172
16.

The business of science and the science of business in the quest for an AIDS vaccine.

Hilleman MR.

Vaccine. 1999 Mar 5;17(9-10):1211-22. Review.

PMID:
10195635
17.

Overview of viruses, cancer, and vaccines in concept and in reality.

Hilleman MR.

Recent Results Cancer Res. 1998;154:345-62. Review.

PMID:
10027015
18.
19.
20.

A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS.

Hilleman MR.

Vaccine. 1998 May;16(8):778-93. Review.

PMID:
9627935
21.

Six decades of vaccine development--a personal history.

Hilleman MR.

Nat Med. 1998 May;4(5 Suppl):507-14. No abstract available.

PMID:
9585201
22.
23.

Strategies for the achievement of prophylactic vaccination against HIV.

Hilleman MR.

Antibiot Chemother (1971). 1996;48:161-72. Review. No abstract available.

PMID:
8726521
25.

DNA vectors. Precedents and safety.

Hilleman MR.

Ann N Y Acad Sci. 1995 Nov 27;772:1-14. Review. No abstract available.

PMID:
8546382
26.

Whether and when an AIDS vaccine?

Hilleman MR.

Nat Med. 1995 Nov;1(11):1126-9. No abstract available.

PMID:
7584976
27.

Viral vaccines in historical perspective.

Hilleman MR.

Dev Biol Stand. 1995;84:107-16. No abstract available.

PMID:
7796942
28.

Comparative biology and pathogenesis of AIDS and hepatitis B viruses: related but different.

Hilleman MR.

AIDS Res Hum Retroviruses. 1994 Nov;10(11):1409-19. Review.

PMID:
7888194
29.
30.

Recombinant vector vaccines in vaccinology.

Hilleman MR.

Dev Biol Stand. 1994;82:3-20. Review.

PMID:
7958480
31.

The promise and the reality of viral vaccines against cancer.

Hilleman MR.

Ann N Y Acad Sci. 1993 Aug 12;690:6-18. Review. No abstract available.

PMID:
8396379
32.

Hepatitis and hepatitis A vaccine: a glimpse of history.

Hilleman MR.

J Hepatol. 1993;18 Suppl 2:S5-10.

PMID:
8182274
33.

A tribute to Dr. Friedrich W. Deinhardt M.D. 1926-1992.

Hilleman MR.

J Hepatol. 1993;18 Suppl 2:S2-4. No abstract available.

PMID:
8182267
34.
35.

Past, present, and future of measles, mumps, and rubella virus vaccines.

Hilleman MR.

Pediatrics. 1992 Jul;90(1 Pt 2):149-53. No abstract available.

PMID:
1603640
36.

Historical and contemporary perspectives in vaccine developments: from the vantage of cancer.

Hilleman MR.

Prog Med Virol. 1992;39:1-18. Review. No abstract available.

PMID:
1594774
37.
38.

Human hepatitis B vaccine from recombinant yeast. 1984.

McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR.

Biotechnology. 1992;24:500-2. No abstract available.

PMID:
1422061
40.

Improving the heat stability of vaccines: problems, needs, and approaches.

Hilleman MR.

Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S613-6. Review.

PMID:
2669105
41.

Conclusions: in pursuit of an AIDS virus vaccine.

Hilleman MR.

Immunol Ser. 1989;44:605-20. Review. No abstract available.

PMID:
2489125
42.

Present status of recombinant hepatitis B vaccine.

Hilleman MR.

Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1988 Dec;29 Suppl B:8B-15B. No abstract available.

PMID:
2978836
43.

Hepatitis B and AIDS and the promise for their control by vaccines.

Hilleman MR.

Vaccine. 1988 Apr;6(2):175-9. Review.

PMID:
3291455
44.

Haemophilus influenzae type b polysaccharide-protein conjugate vaccine.

Tai JY, Vella PP, McLean AA, Woodhour AF, McAleer WJ, Sha A, Dennis-Sykes C, Hilleman MR.

Proc Soc Exp Biol Med. 1987 Feb;184(2):154-61.

PMID:
3543938
45.

Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology.

Hilleman MR, Gerety RJ, Ellis RW.

Dev Biol Stand. 1987;68:5-7. No abstract available.

PMID:
3691963
46.

Yeast recombinant hepatitis B vaccine.

Hilleman MR.

Infection. 1987 Jan-Feb;15(1):3-7.

PMID:
2437037
47.

New findings in live, attenuated hepatitis A vaccine development.

Provost PJ, Bishop RP, Gerety RJ, Hilleman MR, McAleer WJ, Scolnick EM, Stevens CE.

J Med Virol. 1986 Oct;20(2):165-75.

PMID:
3021899
48.

Vaccines made from recombinant yeast cells.

Hilleman MR, Ellis R.

Vaccine. 1986 Jun;4(2):75-6.

PMID:
3014772
49.

The science of vaccines in present and future perspective.

Hilleman MR.

Med J Aust. 1986 Mar 31;144(7):360-4.

PMID:
2937993
50.

Recombinant yeast hepatitis B vaccine.

Hilleman MR.

Dev Biol Stand. 1986;63:57-62. No abstract available.

PMID:
3527821

Supplemental Content

Loading ...
Support Center